HPR180 Eligibility of Orphan Drugs for Preferential Reimbursement in Egypt

Autor: Fasseeh, AN, Elezbawy, B, Korra, N, Roushdy, M, Seyam, A, Hayek, N, Abdel Rahman, N, Abdelhamid, S, Fasseeh, N, Saad, AS, Elagamy, A, Mahmoud, A, Sedrak, AS, Elshazly, K, Eldebeiky, M, Talaat, M, Maher, N, Abdelaziz, R, Refaat, R, Akeel, S, Adel, R, Khalil, S, Abaza, S, Kalo, Z
Zdroj: In Value in Health December 2022 25(12) Supplement:S265-S265
Databáze: ScienceDirect